Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest

FASEB Journal

Volumn 26, Issue 4, 2012, Pages 1431-1441

  Levett, Denny Z ^a   Radford, Elizabeth J ^b   Menassa, David A ^b   Graber, E Franziska ^c   Morash, Andrea J ^b   Hoppeler, Hans ^c   Clarke, Kieran ^d   Martin, Daniel S ^a   Ferguson Smith, Anne C ^b   Montgomery, Hugh E ^e   Grocott, Michael P W ^a   Murray, Andrew J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Energetics; Metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCOUPLING PROTEIN 3;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; CELL HYPOXIA; ENERGY METABOLISM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOBARISM; MOUNTAINEERING; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ACCLIMATIZATION; ADULT; ALTITUDE; ANOXIA; BIOPSY; ENERGY METABOLISM; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MOUNTAINEERING; MUSCLE PROTEINS; MUSCLE, SKELETAL; RNA; TRANSCRIPTION, GENETIC;

EID: 84860895504     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-197772     Document Type: Article

References (53)

1. Grocott, M., Montgomery, H., and Vercueil, A. (2007) High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit. Care 11, 203
2. Khosravi, M., and Grocott, M. (2009) Mountainside to bedside: reality or fiction? Expert Rev. Resp. Med. 3, 561-565
3. Raguso, C. A., Guinot, S. L., Janssens, J. P., Kayser, B., and Pichard, C. (2004) Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr. Opin. Clin. Nutr. Metab. Care 7, 411-417 (Pubitemid 40340648)
4. Peacock, A. J. (1998) ABC of oxygen: oxygen at high altitude. BMJ 317, 1063-1066
5. Sutton, J. R., Reeves, J. T., Wagner, P. D., Groves, B. M., Cymerman, A., Malconian, M. K., Rock, P. B., Young, P. M., Walter, S. D., and Houston, C. S. (1988) Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J. Appl. Physiol. 64, 1309-1321
6. Murray, A. J. (2009) Metabolic adaptation of skeletal muscle to high altitude hypoxia: how new technologies could resolve the controversies. Genome Med. 1, 117
7. Holloway, C. J., Montgomery, H. E., Murray, A. J., Cochlin, L. E., Codreanu, I., Hopwood, N., Johnson, A. W., Rider, O. J., Levett, D. Z., Tyler, D. J., Francis, J. M., Neubauer, S., Grocott, M. P., and Clarke, K. (2011) Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J. 25, 792-796
8. Edwards, L. M., Murray, A. J., Tyler, D. J., Kemp, G. J., Holloway, C. J., Robbins, P. A., Neubauer, S., Levett, D., Montgomery, H. E., Grocott, M. P., and Clarke, K. (2010) The effect of high-altitude on human skeletal muscle energetics: P-MRS results from the Caudwell Xtreme Everest expedition. PLoS ONE 5, e10681
9. Semenza, G. L. (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8
10. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472 (Pubitemid 32335942)
11. Reynafarje, B. (1962) Myoglobin content and enzymatic activity of muscle and altitude adaptation. J. Appl. Physiol. 17, 301-305
12. Howald, H., and Hoppeler, H. (2003) Performing at extreme altitude: muscle cellular and subcellular adaptations. Eur. J. Appl. Physiol. 90, 360-364 (Pubitemid 37455695)
13. Ferretti, G. (2003) Limiting factors to oxygen transport on Mount Everest 30 years after: a critique of Paolo Cerretelli's contribution to the study of altitude physiology. Eur. J. Appl. Physiol. 90, 344-350
14. Youle, R. J., and Narendra, D. P. (2011) Mechanisms of mitophagy. Nat. Rev. Mol. Cell. Biol. 12, 9-14
15. Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., Lowell, B. B., Bassel-Duby, R., and Spiegelman, B. M. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slowtwitch muscle fibres. Nature 418, 797-801
16. Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., and Semenza, G. L. (2007) HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420 (Pubitemid 46670080)
17. Green, H. J., Sutton, J. R., Wolfel, E. E., Reeves, J. T., Butterfield, G. E., and Brooks, G. A. (1992) Altitude acclimatization and energy metabolic adaptations in skeletal muscle during exercise. J. Appl. Physiol. 73, 2701-2708 (Pubitemid 23019690)
18. Gore, C. J., Clark, S. A., and Saunders, P. U. (2007) Nonhematological mechanisms of improved sea-level performance after hypoxic exposure. Med. Sci. Sports Exerc. 39, 1600-1609 (Pubitemid 47360985)
19. McCarthy, J., Lochner, A., Opie, L. H., Sack, M. N., and Essop, M. F. (2011) PKCepsilon promotes cardiac mitochondrial and metabolic adaptation to chronic hypobaric hypoxia by GSK3beta inhibition. J. Cell. Physiol. 226, 2457-2468
20. Gilde, A. J., van der Lee, K. A., Willemsen, P. H., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., and van Bilsen, M. (2003) Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 92, 518-524 (Pubitemid 36368664)
21. Murray, A. J., Panagia, M., Hauton, D., Gibbons, G. F., and Clarke, K. (2005) Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. Diabetes 54, 3496-3502 (Pubitemid 43334341)
22. Narravula, S., and Colgan, S. P. (2001) Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 166, 7543-7548 (Pubitemid 32525634)
23. Aragones, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N. H., Lambrechts, D., Bishop, T., Lafuste, P., Diez- Juan, A., Harten, S. K., Van Noten, P., De Bock, K., Willam, C., Tjwa, M., Grosfeld, A., Navet, R., Moons, L., Vandendriessche, T., Deroose, C., Wijeyekoon, B., Nuyts, J., Jordan, B., Silasi- Mansat, R., Lupu, F., Dewerchin, M., Pugh, C., Salmon, P., Mortelmans, L., Gallez, B., Gorus, F., Buyse, J., Sluse, F., Harris, R. A., Gnaiger, E., Hespel, P., Van Hecke, P., Schuit, F., Van Veldhoven, P., Ratcliffe, P., Baes, M., Maxwell, P., and Carmeliet, P. (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170-180 (Pubitemid 351171394)
24. Levett, D. Z., Martin, D. S., Wilson, M. H., Mitchell, K., Dhillon, S., Rigat, F., Montgomery, H. E., Mythen, M. G., and Grocott, M. P. (2010) Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia. BMC Med. Res. Methodol. 10, 98
25. Hoppeler, H., Luthi, P., Claassen, H., Weibel, E. R., and Howald, H. (1973) The ultrastructure of the normal human skeletal muscle. A morphometric analysis on untrained men, women and well-trained orienteers. Pflügers Arch. 344, 217-232
26. Hoppeler, H. (1986) Exercise-induced ultrastructural changes in skeletal muscle. Int. J. Sports Med. 7, 187-204
27. Vock, R., Weibel, E. R., Hoppeler, H., Ordway, G., Weber, J. M., and Taylor, C. R. (1996) Design of the oxygen and substrate pathways. V. Structural basis of vascular substrate supply to muscle cells. J. Exp. Biol. 199, 1675-1688 (Pubitemid 26310703)
28. Murray, A. J., Cole, M. A., Lygate, C. A., Carr, C. A., Stuckey, D. J., Little, S. E., Neubauer, S., and Clarke, K. (2008) Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J. Mol. Cell. Cardiol. 44, 694-700
29. McClelland, G. B., Dalziel, A. C., Fragoso, N. M., and Moyes, C. D. (2005) Muscle remodeling in relation to blood supply: implications for seasonal changes in mitochondrial enzymes. J. Exp. Biol. 208, 515-522 (Pubitemid 40307434)
30. Houle-Leroy, P., Garland, T., Jr., Swallow, J. G., and Guderley, H. (2000) Effects of voluntary activity and genetic selection on muscle metabolic capacities in house mice Mus domesticus. J. Appl. Physiol. 89, 1608-1616
31. West, J. B., Lahiri, S., Maret, K. H., Peters, R. M., Jr., and Pizzo, C. J. (1983) Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J. Appl. Physiol. 54, 1188-1194 (Pubitemid 13098962)
32. Grocott, M. P., Martin, D. S., Levett, D. Z., McMorrow, R., Windsor, J., and Montgomery, H. E. (2009) Arterial blood gases and oxygen content in climbers on Mount Everest. New Engl. J. Med. 360, 140-149
33. Kim, J. W., and Dang, C. V. (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 66, 8927-8930
34. Vidal-Puig, A., Solanes, G., Grujic, D., Flier, J. S., and Lowell, B. B. (1997) UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 235, 79-82 (Pubitemid 27302688)
35. Brand, M. D., Pamplona, R., Portero-Otin, M., Requena, J. R., Roebuck, S. J., Buckingham, J. A., Clapham, J. C., and Cadenas, S. (2002) Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem. J. 368, 597-603 (Pubitemid 35454538)
36. Lu, Z., and Sack, M. N. (2008) ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3. J. Biol. Chem. 283, 23410-23418
37. Ljubicic, V., Adhihetty, P. J., and Hood, D. A. (2004) Role of UCP3 in state 4 respiration during contractile activity-induced mitochondrial biogenesis. J. Appl. Physiol. 97, 976-983 (Pubitemid 39121422)
38. Boyer, S. J., and Blume, F. D. (1984) Weight loss and changes in body composition at high altitude. J. Appl. Physiol. 57, 1580-1585 (Pubitemid 15216459)
39. Shukla, V., Singh, S. N., Vats, P., Singh, V. K., Singh, S. B., and Banerjee, P. K. (2005) Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutr. Neurosci. 8, 161-165 (Pubitemid 41131432)
40. Cogswell, A. M., Stevens, R. J., and Hood, D. A. (1993) Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am. J. Physiol. 264, C383-C389 (Pubitemid 23072448)
41. Koves, T. R., Noland, R. C., Bates, A. L., Henes, S. T., Muoio, D. M., and Cortright, R. N. (2005) Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am. J. Physiol. Cell Physiol. 288, C1074-C1082 (Pubitemid 40559383)
42. Chandel, N., Budinger, G. R., Kemp, R. A., and Schumacker, P. T. (1995) Inhibition of cytochrome-c oxidase activity during prolonged hypoxia. Am. J. Physiol. 268, L918-L925
43. Wheaton, W. W., and Chandel, N. S. (2011) Hypoxia. 2. Hypoxia regulates cellular metabolism. Am. J. Physiol. Cell Physiol. 300, C385-393
44. Fukuda, R., Zhang, H., Kim, J. W., Shimoda, L., Dang, C. V., and Semenza, G. L. (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129, 111-122 (Pubitemid 46507584)
45. Chan, S. Y., Zhang, Y. Y., Hemann, C., Mahoney, C. E., Zweier, J. L., and Loscalzo, J. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10, 273-284
46. Chen, Z., Li, Y., Zhang, H., Huang, P., and Luthra, R. (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29, 4362-4368
47. Favaro, E., Ramachandran, A., McCormick, R., Gee, H., Blancher, C., Crosby, M., Devlin, C., Blick, C., Buffa, F., Li, J. L., Vojnovic, B., Pires das Neves, R., Glazer, P., Iborra, F., Ivan, M., Ragoussis, J., and Harris, A. L. (2010) MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5, e10345
48. Mogensen, M., Bagger, M., Pedersen, P. K., Fernstrom, M., and Sahlin, K. (2006) Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency. J. Physiol. 571, 669-681 (Pubitemid 43329555)
49. Murray, A. J., Knight, N. S., Cochlin, L. E., McAleese, S., Deacon, R. M., Rawlins, J. N., and Clarke, K. (2009) Deterioration of physical performance and cognitive function in rats with shortterm high-fat feeding. FASEB J. 23, 4353-4360
50. Essop, M. F., Razeghi, P., McLeod, C., Young, M. E., Taegtmeyer, H., and Sack, M. N. (2004) Hypoxia-induced decrease of UCP3 gene expression in rat heart parallels metabolic gene switching but fails to affect mitochondrial respiratory coupling. Biochem. Biophys. Res. Commun. 314, 561-564 (Pubitemid 38084755)
51. Gilde, A. J., and Van Bilsen, M. (2003) Peroxisome proliferatoractivated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol. Scand. 178, 425-434 (Pubitemid 36960434)
52. Kim, J. W., Tchernyshyov, I., Semenza, G. L., and Dang, C. V. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177-185
53. Carre, J. E., Orban, J. C., Re, L., Felsmann, K., Iffert, W., Bauer, M., Suliman, H. B., Piantadosi, C. A., Mayhew, T. M., Breen, P., Stotz, M., and Singer, M. (2010) Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am. J. Respir. Crit. Care Med. 182, 745-751